SPOTLIGHT: BMS to unveil (big?) layoffs


Employees at Bristol-Myers Squibb will be left waiting a few more days before they hear just how bad rumored layoffs will be. The company says it will reveal all next Wednesday, during investors day. One Wall Street analyst expects the company to axe up to one in five staffers and shutter a range of facilities. Report | Report

Suggested Articles

Insitro picked up $143 million to build out its technology, pursue new targets and advance treatments for genetically defined patient groups.

Generation Bio filed for a $215 million IPO to advance a pair of gene therapies for liver disease and push one of them into the clinic.

The IPO will push Avidity's lead muscle disorder program through IND-enabling studies and into the clinic in 2021.